Outcome of Antiretroviral Therapy and Its Predictors Among Clients Enrolled to Community Differentiated ART Service Delivery Model in Amhara Region, Ethiopia, 2024; Multi-Centered Retrospective Follow up Study
Jan 2026· Journal of the International Association of Providers of AIDS Care· Vol 25· 0 citations· 44 references
Medicine
TL;DR
Strengthening retention, tuberculosis prophylaxis, drug supply, and adherence support could improve survival, and treatment outcomes were suboptimal.
Abstract
Background Community-based ART service delivery brings HIV care closer to clinically stable clients and may improve outcomes while reducing burdens on patients and health facilities. However, evidence from low income setting remains limited. Methods Institution based retrospective follow-up study was conducted from 422 adult ART users selected by simple random sampling. Data were analyzed using STATA 15. Multivariable Cox proportional hazards regression identified predictors of treatment outcomes. Results The cumulative incidence of good ART treatment outcome was 81.99% (95% CI: 77.98–85.54%). Median survival time was 11 months (IQR: 5–12). Missing ART doses reduced survival by 54% (AHR=0.46; 95% CI: 0.22–0.95). Good retention in care (AHR=1.58), tuberculosis prophylaxis (AHR=1.38), and adequate drug supply (AHR=1.39) significantly improved survival. Conclusion Treatment outcomes were suboptimal. Strengthening retention, tuberculosis prophylaxis, drug supply, and adherence support could improve survival.
Viral suppression and ART adherence were high among AYLHIV in AFRICOS and clinic site and ART regimen were associated with outcomes, highlighting the importance of health system factors.
M. Brault, Aima A. Ahonkhai, Seth Frndak et al.· Journal of Acquired Immune D...· 0 citations
ART adherence among youth is shaped by an interacting web of family support, treatment fatigue, and health-system efficiency, rather than by any single dominant factor.
Kalega William, Otwine Anne, J. Amanyire· International Journal of Sci...· 0 citations
Background Global reports of tuberculosis (TB) in 2024 estimated 10.7 million cases, of which 5.8% were HIV‐positive individuals. Despite the implementation of TB preventive therapy, TB incidence rates remain high, especially among HIV‐infected patients. Methods A retrospective cohort study was conducted from 1 October...
E. Etu, Edao Wajiso Kallo, Kelil Husen Lenbo et al.· Journal of Tropical Medicine· 0 citations
Background The human immunodeficiency virus (HIV) epidemic remains a major global health concern. While antiretroviral therapy (ART) has significantly improved survival rates, regimen changes during long-term treatment are common and may impact clinical outcomes. Data regarding the incidence rate and determinants of AR...
I. Somia, I. Utama, Anak Agung Ayu Yuli Gayatri et al.· Infection & Chemotherapy· 0 citations
Despite expanded access to antiretroviral therapy (ART), HIV-related mortality remains a concern in resource-limited settings. We assessed all-cause mortality and the factors associated with death among adults receiving ART in the Sughd region of Tajikistan.
We conducted a retrospective cohort study of adu...
E. Qurbonov, R. Horth, A. Mirzoev et al.· BMC Public Health· 0 citations
Background Dolutegravir (DTG)-based antiretroviral therapy is widely used in sub-Saharan Africa, but routine-care evidence on incident hyperglycemia after DTG initiation or substitution remains limited in southwestern Uganda. Purpose To determine the incidence and predictors of documented hyperglycemia among adults rec...